-
Loading metrics
Open Access
Peer-reviewed
Research Article
Ceacam1 Separates Graft-versus-Host-Disease from Graft-versus-Tumor Activity after Experimental Allogeneic Bone Marrow Transplantation
-
Sydney X. Lu,
Affiliation Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
⨯ -
Lucy W. Kappel ,
Contributed equally to this work with: Lucy W. Kappel, Anne-Marie Charbonneau-Allard, Renée Atallah
Affiliations Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Department of Immunology, Weill Cornell Graduate School of Medical Sciences, New York, New York, United States of America
⨯ -
Anne-Marie Charbonneau-Allard ,
Contributed equally to this work with: Lucy W. Kappel, Anne-Marie Charbonneau-Allard, Renée Atallah
Affiliation Goodman Cancer Center and Departments of Biochemistry, Medicine, and Oncology, McGill Cancer Center, Montreal, Quebec, Canada
⨯ -
Renée Atallah ,
Contributed equally to this work with: Lucy W. Kappel, Anne-Marie Charbonneau-Allard, Renée Atallah
Affiliation Goodman Cancer Center and Departments of Biochemistry, Medicine, and Oncology, McGill Cancer Center, Montreal, Quebec, Canada
⨯ -
Amanda M. Holland,
Affiliations Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Department of Immunology, Weill Cornell Graduate School of Medical Sciences, New York, New York, United States of America
⨯ -
Claire Turbide,
Affiliation Goodman Cancer Center and Departments of Biochemistry, Medicine, and Oncology, McGill Cancer Center, Montreal, Quebec, Canada
⨯ -
Vanessa M. Hubbard,
Affiliations Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Department of Pathology, Albert Einstein College of Medicine, Bronx, New York, United States of America
⨯ -
Jimmy A. Rotolo,
Affiliation Department of Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
⨯ -
Marsinay Smith,
Affiliation Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
⨯ -
David Suh,
Affiliation Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
⨯ -
Christopher King,
Affiliation Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
⨯ -
Uttam K. Rao,
Affiliation Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
⨯ -
Nury Yim,
Affiliation Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
⨯ -
Johanne L. Bautista,
Affiliation Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
⨯ -
Robert R. Jenq,
Affiliation Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
⨯ -
Olaf Penack,
Affiliations Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Department of Hematology and Oncology, Charité CBF - Universitätsmedizin Berlin, Berlin, Germany
⨯ -
Il-Kang Na,
Affiliations Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Department of Hematology and Oncology, Charité CBF - Universitätsmedizin Berlin, Berlin, Germany
⨯ -
Chen Liu,
Affiliation Department of Pathology, University of Florida College of Medicine, Gainesville, Florida, United States of America
⨯ -
George Murphy,
Affiliation Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America
⨯ -
Onder Alpdogan,
Affiliations Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Department of Medicine, Yale University Medical School, New Haven, Connecticut, United States of America
⨯ -
Richard S. Blumberg,
Affiliation Department of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America
⨯ -
Fernando Macian,
Affiliation Department of Pathology, Albert Einstein College of Medicine, Bronx, New York, United States of America
⨯ -
Kathryn V. Holmes,
Affiliation Department of Microbiology, University of Colorado School of Medicine, Aurora, Colorado, United States of America
⨯ -
Nicole Beauchemin ,
¶These authors also contributed equally to this work.
Affiliation Goodman Cancer Center and Departments of Biochemistry, Medicine, and Oncology, McGill Cancer Center, Montreal, Quebec, Canada
⨯ - [ ... ],
-
Marcel R. M. van den Brink
¶These authors also contributed equally to this work.
Affiliation Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
⨯ - [ view all ]
- [ view less ]
Ceacam1 Separates Graft-versus-Host-Disease from Graft-versus-Tumor Activity after Experimental Allogeneic Bone Marrow Transplantation
- Sydney X. Lu,
- Lucy W. Kappel,
- Anne-Marie Charbonneau-Allard,
- Renée Atallah,
- Amanda M. Holland,
- Claire Turbide,
- Vanessa M. Hubbard,
- Jimmy A. Rotolo,
- Marsinay Smith,
- David Suh
- Published: July 6, 2011
- https://doi.org/10.1371/journal.pone.0021611